Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study
**Background:** Prescription drug insurance in Canada is constituted of a patchwork of public and private insurance plans. The type of drug insurance may have a negative impact on access to treatment for patients covered by public plans compared with private plans. **Objectives:** In patients with p...
Saved in:
Main Authors: | Laurence Mainville, Hélène Veillette, Paul R. Fortin |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2025-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.127820 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic factors in severe dengue patients: A multi-center retrospective cohort study.
by: Cheng-Hsun Yang, et al.
Published: (2025-01-01) -
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01) -
Hyperglycemia Is a Potential Prognostic Factor for Exacerbation in Severe Psoriasis with Diabetes or Prediabetes
by: Yongpisarn T, et al.
Published: (2025-02-01) -
Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
by: Ramtin Lichtenberger, et al.
Published: (2025-02-01) -
Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study
by: Nicolás Tentoni, et al.
Published: (2024-09-01)